HCA Healthcare Past Earnings Performance

Past criteria checks 2/6

HCA Healthcare has been growing earnings at an average annual rate of 13%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 6.4% per year. HCA Healthcare's return on equity is 574.6%, and it has net margins of 8.1%.

Key information

13.0%

Earnings growth rate

17.9%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate6.4%
Return on equity574.6%
Net Margin8.1%
Next Earnings Update26 Apr 2024

Recent past performance updates

Recent updates

Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong

Apr 11
Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong

HCA Healthcare Is Finally At Fair Value (Rating Downgrade)

Mar 19

HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)

Feb 29

HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66

Feb 25
HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66

HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year

Feb 05
HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year

HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02
HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results

HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate

Jan 21
HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate

At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?

Jan 08
At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?

HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings

Dec 25
HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings

HCA Healthcare Continues To Impress

Dec 14

Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?

Dec 11
Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?

HCA Remains Attractive Despite A JV Misstep

Nov 20

These 4 Measures Indicate That HCA Healthcare (NYSE:HCA) Is Using Debt Extensively

Oct 26
These 4 Measures Indicate That HCA Healthcare (NYSE:HCA) Is Using Debt Extensively

HCA Healthcare: Rx For Success

Oct 10

A Look Into HCA Healthcare's (NYSE:HCA) Impressive Returns On Capital

Oct 09
A Look Into HCA Healthcare's (NYSE:HCA) Impressive Returns On Capital

HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift

Sep 30

At US$256, Is It Time To Put HCA Healthcare, Inc. (NYSE:HCA) On Your Watch List?

Sep 17
At US$256, Is It Time To Put HCA Healthcare, Inc. (NYSE:HCA) On Your Watch List?

HCA Healthcare Is Beating The Industry

Sep 13

Here's Why HCA Healthcare (NYSE:HCA) Can Manage Its Debt Responsibly

Jul 25
Here's Why HCA Healthcare (NYSE:HCA) Can Manage Its Debt Responsibly

HCA Healthcare (NYSE:HCA) Is Aiming To Keep Up Its Impressive Returns

Jul 10
HCA Healthcare (NYSE:HCA) Is Aiming To Keep Up Its Impressive Returns

HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth

Jul 03

HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 45% Above Its Share Price

Jun 25
HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 45% Above Its Share Price

Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?

Jun 09
Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?

HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 09
HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year

HCA Healthcare (NYSE:HCA) Has Announced That It Will Be Increasing Its Dividend To $0.60

May 25
HCA Healthcare (NYSE:HCA) Has Announced That It Will Be Increasing Its Dividend To $0.60

HCA Healthcare (NYSE:HCA) Has A Pretty Healthy Balance Sheet

Apr 22
HCA Healthcare (NYSE:HCA) Has A Pretty Healthy Balance Sheet

HCA Healthcare (NYSE:HCA) Knows How To Allocate Capital

Apr 04
HCA Healthcare (NYSE:HCA) Knows How To Allocate Capital

Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 45%?

Mar 16
Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 45%?

At US$249, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?

Feb 26
At US$249, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?

HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year

Jan 30
HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year

HCA Healthcare Q4 2022 Earnings Preview

Jan 26

HCA Healthcare: An Investment For Interesting Times

Jan 13

Investors Shouldn't Overlook The Favourable Returns On Capital At HCA Healthcare (NYSE:HCA)

Jan 04
Investors Shouldn't Overlook The Favourable Returns On Capital At HCA Healthcare (NYSE:HCA)

HCA Healthcare: Earnings Growth Ahead With A Below-Market P/E, Shares Appear Attractive

Dec 16

HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Dec 16
HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?

Nov 28
Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?

HCA Healthcare Q3 2022 Earnings Preview

Oct 20

HCA Healthcare's Improving 2023 Margins Make It An Attractive Stock

Oct 04

Does HCA Healthcare (NYSE:HCA) Deserve A Spot On Your Watchlist?

Sep 23
Does HCA Healthcare (NYSE:HCA) Deserve A Spot On Your Watchlist?

HCA Healthcare (NYSE:HCA) Is Reinvesting To Multiply In Value

Sep 05
HCA Healthcare (NYSE:HCA) Is Reinvesting To Multiply In Value

Revenue & Expenses Breakdown
Beta

How HCA Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:HCA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2364,9685,2429940
30 Sep 2363,1625,7169760
30 Jun 2361,9205,7719760
31 Mar 2360,8795,7339760
31 Dec 2260,2335,6439760
30 Sep 2259,8005,3769890
30 Jun 2260,1056,5119890
31 Mar 2259,7206,8069890
31 Dec 2158,7526,9569890
30 Sep 2157,9816,5689230
30 Jun 2156,0164,9679230
31 Mar 2152,6494,5969230
31 Dec 2051,5333,7549230
30 Sep 2050,7633,3998550
30 Jun 2050,1463,3438550
31 Mar 2051,6803,0478550
31 Dec 1951,3363,5058550
30 Sep 1950,0873,49800
30 Jun 1948,8443,64500
31 Mar 1947,7713,68200
31 Dec 1846,6773,78700
30 Sep 1845,9653,19700
30 Jun 1845,2102,86400
31 Mar 1844,4142,70100
31 Dec 1743,6142,21600
30 Sep 1742,6932,66200
30 Jun 1742,2672,85400
31 Mar 1741,8532,85500
31 Dec 1641,4902,89000
30 Sep 1641,0982,55200
30 Jun 1640,6842,38300
31 Mar 1640,2622,23200
31 Dec 1539,6782,12900
30 Sep 1539,0652,07400
30 Jun 1538,4292,14300
31 Mar 1537,7622,11900
31 Dec 1436,9181,87500
30 Sep 1436,1181,77200
30 Jun 1435,3541,61900
31 Mar 1434,5741,55900
31 Dec 1334,1821,55600
30 Sep 1333,7801,44600
30 Jun 1333,3861,44100

Quality Earnings: HCA has high quality earnings.

Growing Profit Margin: HCA's current net profit margins (8.1%) are lower than last year (9.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HCA's earnings have grown by 13% per year over the past 5 years.

Accelerating Growth: HCA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: HCA had negative earnings growth (-7.1%) over the past year, making it difficult to compare to the Healthcare industry average (7.1%).


Return on Equity

High ROE: Whilst HCA's Return on Equity (574.62%) is outstanding, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.